Ppp2r3d inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Ppp2r3d protein, which is a regulatory subunit of protein phosphatase 2A (PP2A), one of the major serine/threonine phosphatases in eukaryotic cells. PP2A plays a critical role in the regulation of various cellular processes, including cell growth, division, and signaling pathways. The Ppp2r3d subunit is part of the regulatory complex that modulates the specificity, localization, and activity of the PP2A holoenzyme. By influencing the assembly and function of the PP2A complex, Ppp2r3d contributes to the fine-tuning of phosphatase activity and, consequently, the dephosphorylation of key proteins involved in signaling cascades. Inhibitors of Ppp2r3d are developed to interfere with its role in regulating PP2A, thereby affecting the downstream processes controlled by this phosphatase.
The development of Ppp2r3d inhibitors involves a multi-step process that begins with a detailed structural analysis of the Ppp2r3d protein and its interactions within the PP2A complex. Techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to elucidate the three-dimensional structure of Ppp2r3d, particularly focusing on the regions involved in binding to other PP2A subunits or interacting with substrates. This structural information is crucial for identifying potential binding sites for inhibitors that can disrupt the function of Ppp2r3d without affecting other components of the PP2A complex. Computational tools such as molecular docking and virtual screening are then used to identify small molecules that can bind to these sites with high specificity and affinity. Once promising inhibitors are identified, they are synthesized and tested in vitro to evaluate their ability to modulate the activity of Ppp2r3d and, by extension, PP2A. Through iterative cycles of optimization, these inhibitors are refined to enhance their potency, selectivity, and stability. The study of Ppp2r3d inhibitors not only provides insights into the regulatory mechanisms of PP2A but also contributes to a deeper understanding of the complex networks of protein phosphorylation and dephosphorylation that govern cellular function and signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Tyrosine kinase inhibitor, may interfere with signaling pathways involved in Ppp2r3d's cellular processes. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR inhibitor, could modulate pathways associated with Ppp2r3d's role in cell proliferation and survival. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, potentially alters signaling pathways relevant to Ppp2r3d's function in cell growth and proliferation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
SRC family kinase inhibitor, might impact pathways linked to Ppp2r3d's role in cellular signaling and proliferation. | ||||||
Afatinib | 439081-18-2 | sc-364398 sc-364398A | 5 mg 10 mg | $112.00 $194.00 | 13 | |
Pan-HER inhibitor, could affect cell growth pathways possibly associated with Ppp2r3d's activities. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
BCL-2 inhibitor, may influence apoptotic pathways that intersect with Ppp2r3d's regulatory role. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $127.00 $178.00 | 2 | |
Multi-kinase inhibitor, could impact various signaling pathways potentially linked to Ppp2r3d's function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
RAF kinase inhibitor, might modulate cell signaling pathways that intersect with Ppp2r3d's role. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, may alter protein degradation pathways potentially connected to Ppp2r3d's function. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Tyrosine kinase inhibitor, could impact cellular processes and pathways where Ppp2r3d is involved. | ||||||